Business Wire

PLANETS

27.9.2021 18:02:10 CEST | Business Wire | Press release

Share
teamLab Planets in Tokyo Opens a Dining Experience, an Art Space, and a Flower Shop on October 8

teamLab Planets TOKYO in Toyosu, Tokyo welcomes “Vegan Ramen UZU Tokyo ” from Kyoto; a new artwork space; and a flower shop where visitors can take home the orchids used in one of the museum’s artworks. “Vegan Ramen UZU Kyoto” opened in Kyoto in March of 2020, becoming hugely popular with hour-long wait times. At “Vegan Ramen UZU Tokyo,” vegan ramen can be enjoyed in the Reversible Rotation - Non-Objective Space or Table of Sky and Fire artwork spaces.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210927005038/en/

There will also be a new flower shop, “teamLab Flower Shop & Art,” where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One , in which visitors become one with over 13,000 orchids. All of these facilities open on Friday, October 8 to the public, not just to teamLab Planets museumgoers.

Vegan Ramen UZU Tokyo : https://vegan-uzu.com/pages/uzu-tokyo-en
teamLab Planets Museum Details: planets.teamlab.art
teamLab Planets Highlight Video: https://youtu.be/xofyyJYYWMY

[Vegan Ramen UZU]

At "Vegan Ramen UZU Kyoto,” which opened in March of 2020 in Gosho-Minami, Kyoto, teamLab was responsible for designing the space and other aspects of the restaurant, where guests can enjoy vegan food while surrounded by art.

Vegan Ramen UZU Tokyo ,” which will open at teamLab Planets , will have vegan ramen available for takeout, as well as to enjoy at the newly-opened Reversible Rotation - Non-Objective Space and Table of Sky and Fire artwork spaces. Flower Vegan Ramen, Green Tea Vegan Ramen, and Vegan Ice Cream will also be available only at “Vegan Ramen UZU Tokyo.”

Official Website: https://vegan-uzu.com/

Media Coverage of “Vegan Ramen UZU Kyoto”

Vegan Ramen Menu

  • Soy Sauce Vegan Ramen
  • Miso Vegan Ramen (Spicy)

[Vegan Ramen UZU Tokyo Only Menu]

  • Green Tea Vegan Ramen
  • Flower Vegan Ramen (Cold)

[New Public Artworks]
Reversible Rotation - Non-Objective Space
teamLab, 2021, Digital Installation, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/reversiblerotation_nonobjective/

The artwork space is freed from the physical boundaries of the surfaces of tables or chairs.

The Spatial Calligraphy rotates in the artwork space, every aspect rotating in the same direction. But because of the special characteristics of Ultrasubjective Space, it can appear to be rotating clockwise or counterclockwise.

Spatial calligraphy is calligraphy drawn in space, a form of calligraphy that teamLab has been exploring since it was founded. The artwork reconstructs calligraphy in three dimensional space to express the depth, speed and power of the brush stroke, and that calligraphy is then flattened using the logical structure teamLab calls ultrasubjective space. The calligraphy shifts between two and three dimensions.

Table of Sky and Fir e
teamLab Architects, 2021
Artwork: https://planets.teamlab.art/tokyo/ew/tableskyfire_planets/

This table reflects the sky and the Universe of Fire Particles Falling from the Sky. The table is connected to the artwork and to the sky.

Human beings need to be connected to the world to live. teamLab hopes that people will eat something on this table while thinking that to live and to eat is to stay connected to the world.

[teamLab Flower Shop & Art]

This is a flower shop where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One (photo above), in which visitors become one with over 13,000 orchids.

Orchids live on even after the flowers have fallen, blooming again and again, sometimes for decades. In order for people to take home a part of the work, we sell tote bags containing a variety of orchids. Those who wish to purchase orchids separately may do so from a more limited selection of orchid species.

[teamLab Planets ]

teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.

By immersing the entire body with other people in these massive body immersive artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.

Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.

[Summary]

Vegan Ramen UZU Tokyo
https://vegan-uzu.com/pages/uzu-tokyo-en
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:30 - 20:00
Sundays 10:30 - 19:00

Closed: same as closed days for teamLab Planets

teamLab Flower Shop & Art
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:00 - 20:00
Sundays 10:00 - 19:00

Closed: same as closed days for teamLab Planets

teamlab Planets TOKYO
https://planets.teamlab.art/tokyo/
#teamLabPlanets

Term: July 7, 2018 - End of 2022
Venue: teamLab Planets TOKYO (6 Chome-1-16 Toyosu, Koto City, Tokyo )
Hours:
September: Mon - Fri 10:00 - 20:00 / Sat, Sun, Holidays 9:00-20:00
October: Mon - Fri 10:00 - 19:00 / Sat 9:00 - 20:00 / Sun 9:00 - 19:00
* Last entry 1 hour before closing
Closed: October 5

Admission:
[Entrance Pass]
Adults (ages 18 and older): JPY 3,200
University / Trade School Students: JPY 2,500
Middle School / High School Students: JPY 2,000
Children (ages 4 - 12): JPY 300
Infants (ages 3 and younger): Free
Seniors (ages 65 and older): JPY 2,400
Visitors with Disabilities: JPY 1,600

teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com/en
* Admission and exhibition hours are subject to change. Please check the official website for the latest information.
* A separate admission fee is required for the newly-opened artwork space Reversible Rotation - Non-Objective Space . This space is also open to visitors other than teamLab Planets museumgoers.

Official Social Media Pages:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets

Measures Against the Spread of COVID-19:
Infection prevention measures such as entry restrictions are being implemented. Please check the website for details.
https://teamlabplanets.dmm.com/en/covid-19

[Press Kit]
https://goo.gl/tQXMLm

[Media Inquiries]
https://goo.gl/forms/fqn8DmGV8WWIntP53

[PLANETS Co., Ltd.]
The managing entity for facilities operations at teamLab Planets TOKYO
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo

[About teamLab]

teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.

teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.

teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba,Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai in November 2019. teamLab Planets , a museum where you walk through water and a garden where you become one with the flowers in Toyosu, Tokyo is on view until the end of 2022. The large-scale permanent exhibition teamLab SuperNature soft opened in Macao in June, 2020. teamLab’s annual life-work exhibition, VOLVO teamLab: A Forest Where Gods Live , is on view in Mifuneyama Rakuen, Takeo Hot Springs, Kyushu until November 7, 2021.

teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.

teamLab is represented by Pace Gallery , Martin Browne Contemporary , and Ikkan Art .

teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART

Link:

ClickThru

Social Media:

https://www.facebook.com/TL.Planets/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye